Skip Navigation

Health Care Videos

How to Get Better Drugs, Sooner, at Lower Costs
1:49:49
December 29, 2020
Bart Madden is the author of the book Free To Choose Medicine: Better Drugs Sooner at Lower Cost; a book that offers a compelling argument for the freedom of every patient, guided by the advice of his or her doctor, to make informed decisions about the use of not-yet-FDA-approved therapeutic drugs, that are in late stages of clinical testing. Mr. Madden is recently retired as a Managing Director of Credit Suisse/Holt after a career in money management and investment research that included the founding of Callard Madden & Associates. During his career, he developed the cash-flow return on investment (CFROI) valuation framework that is widely used today by money management firms worldwide. Mr. Madden is currently an independent researcher and a Senior Fellow at the National Center for Policy Analysis (NCPA). His research has focused on the themes of knowledge building and wealth creation being able to exist simultaneously in businesses, and these themes are represented in his various books including - Value Creation Principles: The Pragmatic Theory of the Firm Begins with Purpose and Ends with Sustainable Capitalism, Wealth Creation: A Systems Mindset for Building and Investing in Businesses for the Long Term, and Reconstructing Your Worldview: The Four Core Beliefs You Need to Solve Complex Business Problems. Mr. Madden is a proponent of the application of systems thinking to public policy, and his work in public policy has resulted in the Free To Choose Medicine (http://freetochoosemedicine.com/) plan, which was originally developed in journal articles published in Regulation, Cancer Biotherapy & Radiopharmaceuticals, and Medical Hypotheses. Mr. Madden is passionate about the passage of a Free To Choose Medicine Act which would be a defining moment for Americans giving control of medical decisions back to individual patients and their doctors.

1:49:49
December 29, 2020
Bart Madden is the author of the book Free To Choose Medicine: Better Drugs Sooner at Lower Cost; a book that offers a compelling argument for the freedom of every patient, guided by the advice of his or her doctor, to make informed decisions about the use of not-yet-FDA-approved therapeutic drugs, that are in late stages of clinical testing. Mr. Madden is recently retired as a Managing Director of Credit Suisse/Holt after a career in money management and investment research that included the founding of Callard Madden & Associates. During his career, he developed the cash-flow return on investment (CFROI) valuation framework that is widely used today by money management firms worldwide. Mr. Madden is currently an independent researcher and a Senior Fellow at the National Center for Policy Analysis (NCPA). His research has focused on the themes of knowledge building and wealth creation being able to exist simultaneously in businesses, and these themes are represented in his various books including - Value Creation Principles: The Pragmatic Theory of the Firm Begins with Purpose and Ends with Sustainable Capitalism, Wealth Creation: A Systems Mindset for Building and Investing in Businesses for the Long Term, and Reconstructing Your Worldview: The Four Core Beliefs You Need to Solve Complex Business Problems. Mr. Madden is a proponent of the application of systems thinking to public policy, and his work in public policy has resulted in the Free To Choose Medicine (http://freetochoosemedicine.com/) plan, which was originally developed in journal articles published in Regulation, Cancer Biotherapy & Radiopharmaceuticals, and Medical Hypotheses. Mr. Madden is passionate about the passage of a Free To Choose Medicine Act which would be a defining moment for Americans giving control of medical decisions back to individual patients and their doctors.
 
35:16
December 22, 2020
Christina Herrin, government relations manager of health policy at The Heartland Institute, discusses the benefits of tele-health with Dr. Colin Banas. COVID-19 has dramatically changed the way we live our daily lives and has given more reason to make tele-health a permanent solution to accessing affordable and quality health care. Colin Banas, MD, MSHA Chief Medical Officer Colin Banas is an Internal Medicine Hospitalist and the former Chief Medical Information Officer for VCU Health System in Richmond, VA prior to stepping down after 15 fulfilling years to pursue consulting. He is proud to have testified before the U.S. Senate and the Office of the National Coordinator (ONC) on the topic of Health IT and the Meaningful Use Program and is a former Health IT Fellow for the ONC. His interests center the role of big-data and analytics on patient outcomes and on novel forms of Clinical Decision Support, those that are outside of the realm of traditional rules and alerts, and include real-time dashboarding and intuitive usability designs. He also helped spearhead the VCU effort to participate in the Open Notes initiative, where patients have access to their clinical documentation in real time. In 2017 Dr. Banas was humbled to receive the HIMSS-AMDIS award for Physician Executive of the Year from his peers. https://drfirst.com/
 
1:10:02
December 17, 2020
Andy Singer, digital media manager at The Heartland Institute, interviews Christina Herrin, government relations manager of health policy, on the future of health care. What will health care look like in 2021? How has COVID-19 exposed policy flaws and how to address needed reform? The discussion focuses on the recent vaccine approval via operation Warp Speed, and the potential to apply similar expedited processes to other disease groups. What should states look to address in the upcoming session? Biden care has been a topic of discussion and one we need to consider combating in 2021.
 
1:42:03
November 25, 2020
In this episode of The Heartland Institute's Health Care News Podcast, Vice President Jim Lakely and Health Care News Managing Editor AnneMarie Schieber let out some frustrations about the way the media and government are mask-shaming the public, locking down our economy again, and giving mixed messages on vaccines and other treatments for COVID-19.
 
12:52
November 18, 2020
Christina Herrin, government relations manager of health policy, interviews AnneMarie Schieber, research fellow and managing editor of Health Care News, Heartland's monthly newspaper for health care reform. The discussion revolves around COVID-19 lockdowns, potential vaccines, and upcoming federal hearings for early at home COVID treatment. Watch the live Senate hearing here: https://www.hsgac.senate.gov/hearings/early-outpatient-treatment-an-essential-part-of-a-covid-19-solution
 
53:46
November 10, 2020
Christina Herrin, government relations manager of health policy, interviews Dr. Mary Ruwart, biomedical researcher and ethicist. Dr. Ruwart holds a BS in biochemistry (1970), and a Ph.D. in biophysics (1974) from Michigan State University. After two and a half years on the faculty of the Department of Surgery at Saint Louis University School of Medicine, Ruwart spent nineteen years as a pharmaceutical research scientist for the Upjohn Company. She currently chairs an IRB (Institutional Review Board), consults with nutraceutical companies, and has been an expert witness against the FDA. One of Ruwart's latest publications: Death by Regulation: http://www.ruwart.com/product/death-regulation) Her website: http://www.ruwart.com/
 
32:12
October 22, 2020
Christina Herrin, government relations manager of health policy, interviews Daniel Savickas, regulatory policy manager at FreedomWorks. The discussion focuses on the Most Favored Nations (MFN) Drug Price Controls Scorecard that FreedomWorks recently launched. (linked below) Looking toward free market solutions and ways the current system can be reformed to lower prescription drug prices. Press Release: https://www.freedomworks.org/content/freedomworks-foundation-launches-mfn-drug-price-controls-scorecard
 
56:52
October 2, 2020
Christina Herrin, government relations manager of health policy, interviews Amber Freed, mother, activist, and founder of SLC6A1 Connect. The prevalence of rare diseases in the U.S. is growing. Nearly 1 out of 10 Americans suffer from a rare disease. For the Freed family and Maxwell her son, time is of the essence to find a cure for SLC6A1. The discussion focuses on rare diseases, finding a cure, and obstacles to bringing new cures to market. LinkedIn o Hashtags/References: @Amber Freed, #SLC6A1, #SLC6A1Connect, #GeneTherapy, #FightLikeAMother, #RareDisease Donate here: slc6a1connect.org/donate-here/ Video of our story: www.youtube.com/watch?v=xbNXxMJ4x…&feature=youtu.be Facebook o Follow & Tag: SLC6A1 Connect Donate here: slc6a1connect.org/donate-here/ Video of our story: www.youtube.com/watch?v=xbNXxMJ4x…&feature=youtu.be Instagram o Follow & Tag: Milestones_For_Maxwell o Hashtag: #SLC6A1 #SLC6A1Connect #Ellen Twitter o Follow & Tag: Maxs_Milestones
 
17:36
September 22, 2020
Christina Herrin, government relations manager of health policy, interviews Twila Brase, RN, PHN on COVID-19 related treatments and government red tape limiting options for patients. The discussion focuses on preventative treatment options, a possible vaccine, mask mandates and regulations in Minnesota that are limiting options for patients. These are the best places to find the work they are doing: CCHF Social Media: Facebook: http://www.facebook.com/cchfreedom Twitter: https://twitter.com/CCHFreedom “The Wedge of Health Freedom” Social Media: Facebook: https://www.facebook.com/WedgeofHealthFreedom Twitter: @WedgeofFreedom https://twitter.com/WedgeofFreedom Twila’s Social Media Twitter: https://twitter.com/twilabrase
 
2:19:17
September 21, 2020
Today, Certificate-of-need, or CON laws, in 35 states cover a host of health care services and facility expansions. These laws were intended to make health care more accessible. Instead, they have hindered growth and stifled competition in the medical marketplace. As cronyism and anticompetitive practices—which are inherent to CON laws—have ravaged markets in all industries, the health care market is no exception. The negative effects of government overreach are seen in high costs and outdated hospitals and technologies. Unleashing the free market would level the playing field within the health care market while providing more choices to patients. COVID-19 has exposed how outmoded and unneeded regulation, putting lives at risk and kept delivery of health care at the whims of politicians, not physicians. Watch this webinar by The Heartland Institute, a free-market think tank, with guest panelists from FreedomWorks and Institute for Justice, to discuss CON laws and their negative impacts on health care innovation and access. Host: Christina Herrin, The Heartland Instituite https://www.heartland.org/about-us/who-we-are/christina-herrin Panelists: AnneMarie Schieber, a research fellow, The Heartland Institute https://www.heartland.org/about-us/who-we-are/annemarie-schieber Key work: https://www.heartland.org/news-opinion/news/lawmakers-fight-for-certificate-of-need-reform-in-missouri-and-tennessee https://heartlanddailynews.com/2020/07/pandemic-exposes-government-barriers-to-ambulance-service/ https://www.heartland.org/news-opinion/news/south-carolina-physicians-call-for-market-based-reforms https://heartlanddailynews.com/2020/03/con-repeal-attracts-more-legislative-support-in-south-carolina/ https://heartlanddailynews.com/2020/03/indiana-bills-address-non-compete-clauses-on-physicians/ Jaimie Cavanaugh, litigator, Institute for Justice https://ij.org/staff/jaimie-cavanaugh/ Key work: https://www.kentucky.com/opinion/op-ed/article238281028.html https://ij.org/report/conning-the-competition/ Josh Withrow, senior policy analyst, FreedomWorks https://www.freedomworks.org/users/jwithrow Key work: https://www.freedomworks.org/content/support-increasing-hospital-capacity-fight-coronavirus-act-hr-6336 https://www.freedomworks.org/content/michigan-sets-unlikely-example-states-deregulate-health-care https://fee.org/articles/americas-hyper-regulated-health-care-industry-has-been-exposed-by-covid-19/
 
1:10:05
July 31, 2020
Christina Herrin, director of Free to Choose Medicine, interviews Meryl Nass, M.D. on COVID-19 related treatments and government red tape limiting options for patients. Patients and doctors deserve the right to make decisions about health care without big brother in the exam room. Dr. Nass points to the barriers preventing proper patient treatment and discusses how we can improve upon the antiquated FDA regulatory system.
 
26:53
July 29, 2020
Christina Herrin, director of Free to Choose Medicine, discusses the impacts of government regulation limiting treatment options for COVID-19 patients with Joseph Brewer, M.D. Doctors are advocating for patient freedom and the right for doctors and patients to have the freedom to choose medicines that might save their lives. Currently, federal red tape is creating a barrier to treatment, and is limiting the freedom doctors have to treat their patients. Bio: Joseph Brewer, MD Plaza Infectious Disease St. Luke’s Hospital of Kansas City Kansas City, Missouri Infectious Disease Specialist Medical Director of Infection Prevention, St. Luke’s Hospital Dr. Brewer has been in practice for over 3 decades. The primary focus is direct patient care, although Dr. Brewer has been involved in numerous clinical research projects over the years, as well.